Lower (50% lower) threshold serum concentrations of Nt-proBNP were used in patients with clinical manifestations of HF, echocardiographic criteria, and BMI > 30 kg/m2, taking into account the high incidence of obesity in the study sample [8]. This evidence concerns the gene NPPB and obesity disorder.